Latest filingAug 31, 2026Most recent Form 4
AURX
Nuo Therapeutics, Inc.
OTCHealthcareSurgical & Medical Instruments & Apparatus
Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$953k2 buys
Total selling$00 sells
Net open-market+$953k1 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period4transactions
- A · Grants / awards · dominant2 · 50%
- P · Open-market buys2 · 50%
Activity by reported role
A joint filing can contribute to multiple roles8transactions
- Chief executive officer · dominant4 · 50%
- Chief financial officer4 · 50%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeJorden David EmersonCommon Stock · Direct
2,070,000Aug 28, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 04 → Sep 04
LessMore
Top insiders
By absolute net value across the selected period- JE+$9.5k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
AURX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| AURX | JORDEN DAVID EMERSON | CEOCFO | buy | 7.98k | $869k | P | — | 08/31 | 08/28 | |
| AURX | JORDEN DAVID EMERSON | CEOCFO | buy | 789 | $84.4k | P | — | 08/31 | 08/27 |
Nuo Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Nuo Therapeutics, Inc.?
JORDEN DAVID EMERSON.
When was the latest reported open-market purchase?
Jorden David Emerson reported a buy on Aug 28, 2026 valued at $869k. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $9,538.81. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.